magent
Deterministic published-formula arithmetic plus ICD-10-CM, RxNorm, and LOINC. Pay in USDC on Base via x402.
The wallet the 402 directs payment to. Its whole payment record — every payer, every chain — is on the merchant page.
Asset 0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913
The payTo wallet does not resolve to a registered ERC-8004 agent. That is not a verdict on the service — most of the catalog is unregistered.
Live 402 challenge
Captured by the enrichment pass, not read just now. Prices can change — always read the 402 the endpoint answers with.
{
"error": "PAYMENT-SIGNATURE header is required",
"accepts": [
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"paymentFlow": "upfront",
"resourceUrl": "https://api.magentlab.com/api/calc/aih_original",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "exact",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
},
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"withdrawDelay": 86400,
"receiverAuthorizer": "0x3721824a31197dcDD2984cF43b92B6cc8A87c0Fb",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "batch-settlement",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
}
],
"resource": {
"url": "https://api.magentlab.com/api/calc/aih_original",
"tags": [
"aih-original",
"autoimmune",
"hepatitis",
"liver",
"calculator"
],
"mimeType": "application/json",
"description": "Alvarez 1999 revised original IAIHG AIH score, not Hennes 2008 simplified. Caller-assigned sex, ALP:AST/ALT ratio, globulin/IgG, ANA/SMA/LKM titer, AMA, viral markers, drugs, alcohol, additive histology, other autoimmune disease; optional HLA/other autoantibodies if seronegative and treatment response. Pretreatment definite >15 / probable 10-15; posttreatment definite >17 / probable 12-17. magent does not read histology. Not a diagnosis or immunosuppression order.",
"serviceName": "magent"
},
"extensions": {
"bazaar": {
"info": {
"input": {
"type": "http",
"method": "GET",
"queryParams": {
"sex": "male",
"alp_ratio": "gt_3",
"ama_positive": true,
"globulin_igg": "lt_1x",
"alcohol_intake": "gt_60",
"hla_dr3_or_dr4": false,
"biliary_changes": true,
"hepatotoxic_drugs": true,
"autoantibody_titer": "lt_1_40",
"treatment_response": "none",
"interface_hepatitis": false,
"liver_cell_rosettes": false,
"other_autoantibodies": false,
"viral_markers_positive": true,
"other_atypical_histology": true,
"other_autoimmune_disease": false,
"lymphoplasmacytic_infiltrate": false
}
},
"output": {
"type": "json",
"example": {
"score": -26,
"timing": "pretreatment",
"formula": "aih_original",
"aih_band": "not_aih",
"citation": {
"id": "alvarez-1999",
"doi": "10.1016/s0168-8278(99)80297-9",
"pmid": "10580593",
"title": "International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis",
"source": "J Hepatol. 1999;31(5):929-938",
"authors": "Alvarez F, Berg PA, Bianchi FB, et al."
},
"max_score": 26,
"components": [
{
"value": "male",
"factor": "sex",
"points": 0,
"present": false
},
{
"value": "gt_3",
"factor": "alp_ratio",
"points": -2,
"present": true
},
{
"value": "lt_1x",
"factor": "globulin_igg",
"points": 0,
"present": false
},
{
"value": "lt_1_40",
"factor": "autoantibody_titer",
"points": 0,
"present": false
},
{
"factor": "ama_positive",
"points": -4,
"present": true
},
{
"value": true,
"factor": "viral_markers_positive",
"points": -3,
"present": true
},
{
"value": true,
"factor": "hepatotoxic_drugs",
"points": -4,
"present": true
},
{
"value": "gt_60",
"factor": "alcohol_intake",
"points": -2,
"present": true
},
{
"factor": "interface_hepatitis",
"points": 0,
"present": false
},
{
"factor": "lymphoplasmacytic_infiltrate",
"points": 0,
"present": false
},
{
"factor": "liver_cell_rosettes",
"points": 0,
"present": false
},
{
"factor": "typical_histology_absent",
"points": -5,
"present": true
},
{
"factor": "biliary_changes",
"points": -3,
"present": true
},
{
"factor": "other_atypical_histology",
"points": -3,
"present": true
},
{
"factor": "other_autoimmune_disease",
"points": 0,
"present": false
},
{
"factor": "other_autoantibodies",
"points": 0,
"present": false
},
{
"factor": "hla_dr3_or_dr4",
"points": 0,
"present": false
},
{
"value": "none",
"factor": "treatment_response",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"formula_expression": "revised original IAIHG AIH (Alvarez 1999) = sex (male 0, female 2) + alp_ratio (lt_1_5 2, 1_5_to_3 0, gt_3 -2) + globulin_igg (lt_1x 0, 1_to_1_5x 1, 1_5_to_2x 2, gt_2x 3) + autoantibody_titer (lt_1_40 0, 1_40 1, 1_80 2, gt_1_80 3) + ama_positive (true -4) + viral_markers (positive -3, negative 3) + hepatotoxic_drugs (true -4, false 1) + alcohol (lt_25 2, 25_to_60 0, gt_60 -2) + histology (interface 3, lymphoplasmacytic 1, rosettes 1, none of those -5, biliary -3, other atypical -3; additive) + other_autoimmune_disease (true 2) + other_autoantibodies (true 2 if titer lt_1_40) + hla_dr3_or_dr4 (true 1 if titer lt_1_40) + treatment_response (complete 2, relapse 3); max 26; pretreatment definite >15, probable 10-15; posttreatment definite >17, probable 12-17"
}
},
"iconUrl": "https://api.magentlab.com/favicon.ico"
},
"schema": {
"type": "object",
"$schema": "https://json-schema.org/draft/2020-12/schema",
"required": [
"input"
],
"properties": {
"input": {
"type": "object",
"required": [
"type",
"method"
],
"properties": {
"type": {
"type": "string",
"const": "http"
},
"method": {
"enum": [
"GET",
"HEAD",
"DELETE"
],
"type": "string"
},
"headers": {
"type": "object",
"additionalProperties": {
"type": "string"
}
},
"queryParams": {
"type": "object",
"required": [
"sex",
"alp_ratio",
"globulin_igg",
"autoantibody_titer",
"ama_positive",
"viral_markers_positive",
"hepatotoxic_drugs",
"alcohol_intake",
"interface_hepatitis",
"lymphoplasmacytic_infiltrate",
"liver_cell_rosettes",
"biliary_changes",
"other_atypical_histology",
"other_autoimmune_disease"
],
"properties": {
"sex": {
"enum": [
"female",
"male"
],
"type": "string",
"description": "Caller-assigned sex (Alvarez 1999). female scores 2; male scores 0. magent does not examine the patient."
},
"alp_ratio": {
"enum": [
"lt_1_5",
"1_5_to_3",
"gt_3"
],
"type": "string",
"description": "Caller-assigned ALP:(AST or ALT) ratio as multiples of ULN (Alvarez 1999 note 1). lt_1_5 (<1.5) scores 2; 1_5_to_3 (1.5–3.0) scores 0; gt_3 (>3) scores -2. magent does not take raw enzymes."
},
"ama_positive": {
"type": "boolean",
"description": "Caller-assigned antimitochondrial antibody. true scores -4; false scores 0 (Alvarez 1999). magent does not assay AMA."
},
"globulin_igg": {
"enum": [
"lt_1x",
"1_to_1_5x",
"1_5_to_2x",
"gt_2x"
],
"type": "string",
"description": "Caller-assigned serum globulin or IgG as multiples of ULN (Alvarez 1999). lt_1x scores 0; 1_to_1_5x scores 1; 1_5_to_2x scores 2; gt_2x scores 3. magent does not assay globulin or IgG."
},
"alcohol_intake": {
"enum": [
"lt_25",
"25_to_60",
"gt_60"
],
"type": "string",
"description": "Caller-assigned average alcohol intake (Alvarez 1999). lt_25 (<25 g/day) scores 2; 25_to_60 scores 0 (gap between the tabulated <25 and >60 cells); gt_60 (>60 g/day) scores -2."
},
"hla_dr3_or_dr4": {
"type": "boolean",
"description": "Optional. HLA DR3 or DR4 (Alvarez 1999 note 9). true scores 1 only when autoantibody_titer is lt_1_40; otherwise 0. Omit or false scores 0."
},
"biliary_changes": {
"type": "boolean",
"description": "Caller-assigned biliary changes typical of PBC or PSC (Alvarez 1999 note 5). true scores -3; additive with other histology items. magent does not read histology."
},
"hepatotoxic_drugs": {
"type": "boolean",
"description": "Recent or current known or suspected hepatotoxic drugs (Alvarez 1999 note 4). true scores -4; false scores 1."
},
"autoantibody_titer": {
"enum": [
"lt_1_40",
"1_40",
"1_80",
"gt_1_80"
],
"type": "string",
"description": "Caller-assigned highest ANA, SMA, or LKM-1 immunofluorescence titer (Alvarez 1999). lt_1_40 scores 0; 1_40 scores 1; 1_80 scores 2; gt_1_80 scores 3. magent does not titer autoantibodies."
},
"treatment_response": {
"enum": [
"none",
"complete",
"relapse"
],
"type": "string",
"description": "Optional. Alvarez 1999 response to therapy, added to presentation points. none or omit: pretreatment bands (definite >15, probable 10-15). complete scores 2; relapse scores 3; both use posttreatment bands (definite >17, probable 12-17). Not an immunosuppression order."
},
"interface_hepatitis": {
"type": "boolean",
"description": "Caller-assigned interface hepatitis on liver histology. true scores 3 (Alvarez 1999; additive). magent does not read histology."
},
"liver_cell_rosettes": {
"type": "boolean",
"description": "Caller-assigned liver-cell rosettes. true scores 1 (Alvarez 1999; additive). magent does not read histology."
},
"other_autoantibodies": {
"type": "boolean",
"description": "Optional. Seropositivity for other defined autoantibodies (pANCA, anti-LC1, anti-SLA, anti-ASGPR, anti-LP, anti-sulfatide; Alvarez 1999 note 8). true scores 2 only when autoantibody_titer is lt_1_40; otherwise 0. Omit or false scores 0."
},
"viral_markers_positive": {
"type": "boolean",
"description": "Caller-assigned hepatitis A/B/C viral markers (Alvarez 1999 note 3). true scores -3; false (negative) scores 3. magent does not interpret viral serology."
},
"other_atypical_histology": {
"type": "boolean",
"description": "Caller-assigned other prominent histologic features suggesting a different etiology (Alvarez 1999 note 6). true scores -3; additive. magent does not read histology."
},
"other_autoimmune_disease": {
"type": "boolean",
"description": "Any other autoimmune disorder in the patient or first-degree relatives (Alvarez 1999 note 7). true scores 2; false scores 0."
},
"lymphoplasmacytic_infiltrate": {
"type": "boolean",
"description": "Caller-assigned predominantly lymphoplasmacytic infiltrate. true scores 1 (Alvarez 1999; additive). magent does not read histology."
}
}
}
},
"additionalProperties": false
},
"output": {
"type": "object",
"required": [
"type"
],
"properties": {
"type": {
"type": "string"
},
"example": {
"type": "object"
}
}
}
}
}
}
},
"x402Version": 2
}Accepts
The payment requirements as published to the catalog. Read the live 402 before paying — a price here is a claim, not a quote.
Pay 0.005 USDC on Base to 0x836B…19Ee2. The signed payment is good for 10 minutes.
- Paid to
- 0x836B…19Ee2
- USD Coin contract
- 0x8335…02913
- Payment window
- 10 minutes
- As published
- 5000 smallest units
The catalog’s raw entry
[
{
"asset": "0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913",
"extra": {
"name": "USD Coin",
"version": "2",
"paymentFlow": "upfront",
"resourceUrl": "https://api.magentlab.com/api/calc/aih_original",
"assetTransferMethod": "eip3009"
},
"payTo": "0x836Be278f1739fB4308091cD1852F7971Bc19Ee2",
"amount": "5000",
"scheme": "exact",
"network": "eip155:8453",
"maxTimeoutSeconds": 600
}
]Extensions
{
"bazaar": {
"info": {
"input": {
"body": {
"items": [
{
"sex": "male",
"alp_ratio": "gt_3",
"ama_positive": true,
"globulin_igg": "lt_1x",
"alcohol_intake": "gt_60",
"hla_dr3_or_dr4": false,
"biliary_changes": true,
"hepatotoxic_drugs": true,
"autoantibody_titer": "lt_1_40",
"treatment_response": "none",
"interface_hepatitis": false,
"liver_cell_rosettes": false,
"other_autoantibodies": false,
"viral_markers_positive": true,
"other_atypical_histology": true,
"other_autoimmune_disease": false,
"lymphoplasmacytic_infiltrate": false
},
{
"sex": "male",
"alp_ratio": "gt_3",
"ama_positive": true,
"globulin_igg": "lt_1x",
"alcohol_intake": "gt_60",
"hla_dr3_or_dr4": false,
"biliary_changes": true,
"hepatotoxic_drugs": true,
"autoantibody_titer": "lt_1_40",
"treatment_response": "none",
"interface_hepatitis": false,
"liver_cell_rosettes": false,
"other_autoantibodies": false,
"viral_markers_positive": true,
"other_atypical_histology": true,
"other_autoimmune_disease": false,
"lymphoplasmacytic_infiltrate": false
}
]
},
"type": "http",
"method": "POST"
},
"output": {
"type": "json",
"example": {
"path": "/api/calc/aih_original",
"count": 2,
"items": [
{
"score": -26,
"timing": "pretreatment",
"formula": "aih_original",
"aih_band": "not_aih",
"citation": {
"id": "alvarez-1999",
"doi": "10.1016/s0168-8278(99)80297-9",
"pmid": "10580593",
"title": "International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis",
"source": "J Hepatol. 1999;31(5):929-938",
"authors": "Alvarez F, Berg PA, Bianchi FB, et al."
},
"max_score": 26,
"components": [
{
"value": "male",
"factor": "sex",
"points": 0,
"present": false
},
{
"value": "gt_3",
"factor": "alp_ratio",
"points": -2,
"present": true
},
{
"value": "lt_1x",
"factor": "globulin_igg",
"points": 0,
"present": false
},
{
"value": "lt_1_40",
"factor": "autoantibody_titer",
"points": 0,
"present": false
},
{
"factor": "ama_positive",
"points": -4,
"present": true
},
{
"value": true,
"factor": "viral_markers_positive",
"points": -3,
"present": true
},
{
"value": true,
"factor": "hepatotoxic_drugs",
"points": -4,
"present": true
},
{
"value": "gt_60",
"factor": "alcohol_intake",
"points": -2,
"present": true
},
{
"factor": "interface_hepatitis",
"points": 0,
"present": false
},
{
"factor": "lymphoplasmacytic_infiltrate",
"points": 0,
"present": false
},
{
"factor": "liver_cell_rosettes",
"points": 0,
"present": false
},
{
"factor": "typical_histology_absent",
"points": -5,
"present": true
},
{
"factor": "biliary_changes",
"points": -3,
"present": true
},
{
"factor": "other_atypical_histology",
"points": -3,
"present": true
},
{
"factor": "other_autoimmune_disease",
"points": 0,
"present": false
},
{
"factor": "other_autoantibodies",
"points": 0,
"present": false
},
{
"factor": "hla_dr3_or_dr4",
"points": 0,
"present": false
},
{
"value": "none",
"factor": "treatment_response",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"formula_expression": "revised original IAIHG AIH (Alvarez 1999) = sex (male 0, female 2) + alp_ratio (lt_1_5 2, 1_5_to_3 0, gt_3 -2) + globulin_igg (lt_1x 0, 1_to_1_5x 1, 1_5_to_2x 2, gt_2x 3) + autoantibody_titer (lt_1_40 0, 1_40 1, 1_80 2, gt_1_80 3) + ama_positive (true -4) + viral_markers (positive -3, negative 3) + hepatotoxic_drugs (true -4, false 1) + alcohol (lt_25 2, 25_to_60 0, gt_60 -2) + histology (interface 3, lymphoplasmacytic 1, rosettes 1, none of those -5, biliary -3, other atypical -3; additive) + other_autoimmune_disease (true 2) + other_autoantibodies (true 2 if titer lt_1_40) + hla_dr3_or_dr4 (true 1 if titer lt_1_40) + treatment_response (complete 2, relapse 3); max 26; pretreatment definite >15, probable 10-15; posttreatment definite >17, probable 12-17"
},
{
"score": -26,
"timing": "pretreatment",
"formula": "aih_original",
"aih_band": "not_aih",
"citation": {
"id": "alvarez-1999",
"doi": "10.1016/s0168-8278(99)80297-9",
"pmid": "10580593",
"title": "International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis",
"source": "J Hepatol. 1999;31(5):929-938",
"authors": "Alvarez F, Berg PA, Bianchi FB, et al."
},
"max_score": 26,
"components": [
{
"value": "male",
"factor": "sex",
"points": 0,
"present": false
},
{
"value": "gt_3",
"factor": "alp_ratio",
"points": -2,
"present": true
},
{
"value": "lt_1x",
"factor": "globulin_igg",
"points": 0,
"present": false
},
{
"value": "lt_1_40",
"factor": "autoantibody_titer",
"points": 0,
"present": false
},
{
"factor": "ama_positive",
"points": -4,
"present": true
},
{
"value": true,
"factor": "viral_markers_positive",
"points": -3,
"present": true
},
{
"value": true,
"factor": "hepatotoxic_drugs",
"points": -4,
"present": true
},
{
"value": "gt_60",
"factor": "alcohol_intake",
"points": -2,
"present": true
},
{
"factor": "interface_hepatitis",
"points": 0,
"present": false
},
{
"factor": "lymphoplasmacytic_infiltrate",
"points": 0,
"present": false
},
{
"factor": "liver_cell_rosettes",
"points": 0,
"present": false
},
{
"factor": "typical_histology_absent",
"points": -5,
"present": true
},
{
"factor": "biliary_changes",
"points": -3,
"present": true
},
{
"factor": "other_atypical_histology",
"points": -3,
"present": true
},
{
"factor": "other_autoimmune_disease",
"points": 0,
"present": false
},
{
"factor": "other_autoantibodies",
"points": 0,
"present": false
},
{
"factor": "hla_dr3_or_dr4",
"points": 0,
"present": false
},
{
"value": "none",
"factor": "treatment_response",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"formula_expression": "revised original IAIHG AIH (Alvarez 1999) = sex (male 0, female 2) + alp_ratio (lt_1_5 2, 1_5_to_3 0, gt_3 -2) + globulin_igg (lt_1x 0, 1_to_1_5x 1, 1_5_to_2x 2, gt_2x 3) + autoantibody_titer (lt_1_40 0, 1_40 1, 1_80 2, gt_1_80 3) + ama_positive (true -4) + viral_markers (positive -3, negative 3) + hepatotoxic_drugs (true -4, false 1) + alcohol (lt_25 2, 25_to_60 0, gt_60 -2) + histology (interface 3, lymphoplasmacytic 1, rosettes 1, none of those -5, biliary -3, other atypical -3; additive) + other_autoimmune_disease (true 2) + other_autoantibodies (true 2 if titer lt_1_40) + hla_dr3_or_dr4 (true 1 if titer lt_1_40) + treatment_response (complete 2, relapse 3); max 26; pretreatment definite >15, probable 10-15; posttreatment definite >17, probable 12-17"
}
]
}
},
"iconUrl": "https://api.magentlab.com/favicon.ico"
},
"schema": {
"type": "object",
"$schema": "https://json-schema.org/draft/2020-12/schema",
"required": [
"input"
],
"properties": {
"input": {
"type": "object",
"required": [
"type",
"method"
],
"properties": {
"body": {
"type": "object",
"required": [
"items"
],
"properties": {
"items": {
"type": "array",
"items": {
"type": "object",
"required": [
"sex",
"alp_ratio",
"globulin_igg",
"autoantibody_titer",
"ama_positive",
"viral_markers_positive",
"hepatotoxic_drugs",
"alcohol_intake",
"interface_hepatitis",
"lymphoplasmacytic_infiltrate",
"liver_cell_rosettes",
"biliary_changes",
"other_atypical_histology",
"other_autoimmune_disease"
],
"properties": {
"sex": {
"enum": [
"female",
"male"
],
"type": "string",
"description": "Caller-assigned sex (Alvarez 1999). female scores 2; male scores 0. magent does not examine the patient."
},
"alp_ratio": {
"enum": [
"lt_1_5",
"1_5_to_3",
"gt_3"
],
"type": "string",
"description": "Caller-assigned ALP:(AST or ALT) ratio as multiples of ULN (Alvarez 1999 note 1). lt_1_5 (<1.5) scores 2; 1_5_to_3 (1.5–3.0) scores 0; gt_3 (>3) scores -2. magent does not take raw enzymes."
},
"ama_positive": {
"type": "boolean",
"description": "Caller-assigned antimitochondrial antibody. true scores -4; false scores 0 (Alvarez 1999). magent does not assay AMA."
},
"globulin_igg": {
"enum": [
"lt_1x",
"1_to_1_5x",
"1_5_to_2x",
"gt_2x"
],
"type": "string",
"description": "Caller-assigned serum globulin or IgG as multiples of ULN (Alvarez 1999). lt_1x scores 0; 1_to_1_5x scores 1; 1_5_to_2x scores 2; gt_2x scores 3. magent does not assay globulin or IgG."
},
"alcohol_intake": {
"enum": [
"lt_25",
"25_to_60",
"gt_60"
],
"type": "string",
"description": "Caller-assigned average alcohol intake (Alvarez 1999). lt_25 (<25 g/day) scores 2; 25_to_60 scores 0 (gap between the tabulated <25 and >60 cells); gt_60 (>60 g/day) scores -2."
},
"hla_dr3_or_dr4": {
"type": "boolean",
"description": "Optional. HLA DR3 or DR4 (Alvarez 1999 note 9). true scores 1 only when autoantibody_titer is lt_1_40; otherwise 0. Omit or false scores 0."
},
"biliary_changes": {
"type": "boolean",
"description": "Caller-assigned biliary changes typical of PBC or PSC (Alvarez 1999 note 5). true scores -3; additive with other histology items. magent does not read histology."
},
"hepatotoxic_drugs": {
"type": "boolean",
"description": "Recent or current known or suspected hepatotoxic drugs (Alvarez 1999 note 4). true scores -4; false scores 1."
},
"autoantibody_titer": {
"enum": [
"lt_1_40",
"1_40",
"1_80",
"gt_1_80"
],
"type": "string",
"description": "Caller-assigned highest ANA, SMA, or LKM-1 immunofluorescence titer (Alvarez 1999). lt_1_40 scores 0; 1_40 scores 1; 1_80 scores 2; gt_1_80 scores 3. magent does not titer autoantibodies."
},
"treatment_response": {
"enum": [
"none",
"complete",
"relapse"
],
"type": "string",
"description": "Optional. Alvarez 1999 response to therapy, added to presentation points. none or omit: pretreatment bands (definite >15, probable 10-15). complete scores 2; relapse scores 3; both use posttreatment bands (definite >17, probable 12-17). Not an immunosuppression order."
},
"interface_hepatitis": {
"type": "boolean",
"description": "Caller-assigned interface hepatitis on liver histology. true scores 3 (Alvarez 1999; additive). magent does not read histology."
},
"liver_cell_rosettes": {
"type": "boolean",
"description": "Caller-assigned liver-cell rosettes. true scores 1 (Alvarez 1999; additive). magent does not read histology."
},
"other_autoantibodies": {
"type": "boolean",
"description": "Optional. Seropositivity for other defined autoantibodies (pANCA, anti-LC1, anti-SLA, anti-ASGPR, anti-LP, anti-sulfatide; Alvarez 1999 note 8). true scores 2 only when autoantibody_titer is lt_1_40; otherwise 0. Omit or false scores 0."
},
"viral_markers_positive": {
"type": "boolean",
"description": "Caller-assigned hepatitis A/B/C viral markers (Alvarez 1999 note 3). true scores -3; false (negative) scores 3. magent does not interpret viral serology."
},
"other_atypical_histology": {
"type": "boolean",
"description": "Caller-assigned other prominent histologic features suggesting a different etiology (Alvarez 1999 note 6). true scores -3; additive. magent does not read histology."
},
"other_autoimmune_disease": {
"type": "boolean",
"description": "Any other autoimmune disorder in the patient or first-degree relatives (Alvarez 1999 note 7). true scores 2; false scores 0."
},
"lymphoplasmacytic_infiltrate": {
"type": "boolean",
"description": "Caller-assigned predominantly lymphoplasmacytic infiltrate. true scores 1 (Alvarez 1999; additive). magent does not read histology."
}
}
},
"maxItems": 25,
"minItems": 1
}
},
"additionalProperties": false
},
"type": {
"type": "string",
"const": "http"
},
"method": {
"type": "string",
"const": "POST"
},
"headers": {
"type": "object",
"additionalProperties": {
"type": "string"
}
}
},
"additionalProperties": false
},
"output": {
"type": "object",
"required": [
"type"
],
"properties": {
"type": {
"type": "string"
},
"example": {
"type": "object"
}
}
}
}
}
}
}Provenance
- Seen in the source catalog
- 2026-08-31 13:05Z
- Last indexed by Roundhouse
- 2026-09-07 06:20Z
- Last enriched (probe, favicon, geo)
- 2026-09-22 18:45Z
- x402 version
- 2
- Max timeout
- 600s
- Liveness probe
- HTTP 402
Hand this page to an agent
Copy the prompt and paste it into Claude, an MCP client or your own agent — it will vet this service and call it over the free read API. No key, no account.
GET api.roundhouseai.io/v0/endpoints
This endpoint's own trailing-30-day call count, as published by the upstream catalog and snapshotted daily. 9 snapshots so far. Verified volume counts only settlements with an on-chain EIP-3009 marker.
Show the promptHide the prompt
Using Roundhouse, look up the x402 service magent and tell me whether it is worth paying: what a call costs, whether the endpoint answered when last probed, and what its payment record actually shows. curl -s 'https://api.roundhouseai.io/v0/endpoints?q=magent' curl -s 'https://api.roundhouseai.io/v0/merchants/<the payTo wallet returned above>' Then call it: read the price from the live 402 at https://api.magentlab.com/api/calc/aih_original, never from a cached figure, and pay with an x402 client. The /v0 API needs an API key (`authorization: Bearer rh_live_…`) on everything except /v0/unified* and /v0/endpoints. Mint a personal key for $0.01 at GET https://api.roundhouseai.io/v0/test/x402, or use an organization key from https://roundhouseai.io/dashboard/team. If you do not have Roundhouse tools or skills installed, read https://roundhouseai.io/skill.md first — it is the whole procedure.